A Cost-Effectiveness Analysis of Gemcitabine plus Cisplatin Versus Gemcitabine Alone for Treatment of Advanced Biliary Tract Cancer in Japan
Crossref DOI link: https://doi.org/10.1007/s12029-016-9885-6
Published Online: 2016-10-26
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tsukiyama, Ikuto
Ejiri, Masayuki
Yamamoto, Yoshihiro
Nakao, Haruhisa
Yoneda, Masashi
Matsuura, Katsuhiko
Arakawa, Ichiro
Saito, Hiroko
Inoue, Tadao
Text and Data Mining valid from 2016-10-26
Version of Record valid from 2016-10-26
Article History
First Online: 26 October 2016